The efficacy of cerebellar vermal deep high frequency (theta range) repetitive transcranial magnetic stimulation (rTMS) in schizophrenia: A randomized rater blind-sham controlled study

Psychiatry Research

Volumn 243, Issue , 2016, Pages 413-420

  Garg, Shobit ^a   Sinha, Vinod Kumar ^b   Tikka, Sai Krishna ^b   Mishra, Preeti ^a   Goyal, Nishant ^b  

^a Shri Mahant Indiresh Hospital   (India)

^b CENTRAL INSTITUTE OF PSYCHIATRY   (India)

Author keywords

Cerebellum; Schizophrenia; Transcranial magnetic stimulation

Indexed keywords

ANALGESIC AGENT;

ADULT; ARTICLE; CALGARY DEPRESSION SCALE; CEREBELLAR STIMULATOR; CEREBELLUM VERMIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HIGH FREQUENCY ELECTROTHERAPY; HUMAN; MALE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOMNOLENCE; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; BRAIN DEPTH STIMULATION; HALLUCINATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; THETA RHYTHM; TREATMENT OUTCOME;

ADULT; CEREBELLAR VERMIS; DEEP BRAIN STIMULATION; DOUBLE-BLIND METHOD; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; THETA RHYTHM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84978828203     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2016.07.023     Document Type: Article

References (73)

1. Addington, D., Addington, J., Schissel, B., A depression rating scale for schizophrenics. Schizophr. Res. 3 (1990), 247–251.
2. Andrade, C., Kisely, S., Monteiro, I., Rao, S., Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: systematic review and meta-analysis of randomized controlled trials. J. Psychiatr. Res. 60 (2015), 14–21.
3. Andreasen, N.C., O'Leary, D.S., Flaum, M., Nopoulos, P., Watkins, G.L., Ponto, L.L.B., Hichwa, R.D., Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet 349 (1997), 1730–1734.
4. Andreasen, N.C., Pierson, R., The role of the cerebellum in schizophrenia. Biol. Psychiatry 64 (2008), 81–88.
5. Bernard, J.A., Mittal, V.A., Dysfunctional activation of the cerebellum in schizophrenia: a functional neuroimaging meta-analysis. Clin. Psychol. Sci. 3 (2015), 545–566.
6. Brunoni, A.R., Shiozawa, P., Truong, D., Javitt, D.C., Elkis, H., Fregni, F., Bikson, M., Understanding tDCS effects in schizophrenia: A systematic review of clinical data and an integrated computation modeling analysis. Expert Rev. Med. Devices 11 (2014), 383–394.
7. Chen, X., Hong, Y., Zheng, P., Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Psychiatry Res. 228 (2015), 121–127.
8. Chen, Y.L., Tu, P.C., Lee, Y.C., Chen, Y.S., Li, C.T., Su, T.P., Resting-state fMRI mapping of cerebellar functional dysconnections involving multiple large-scale networks in patients with schizophrenia. Schizophr. Res. 149 (2013), 26–34.
9. Cole, J.C., Green Bernacki, C., Helmer, A., Pinninti, N., O'reardon, J.P., Efficacy of Transcranial Magnetic Stimulation (TMS) in the treatment of schizophrenia: a review of the literature to date. Innov. Clin. Neurosci. 12 (2015), 12–19.
10. Del Olmo, M.F., Cheeran, B., Koch, G., Rothwell, J.C., Role of the cerebellum in externally paced rhythmic finger movements. J. Neurophysiol. 98 (2007), 145–152.
11. Demirtas-Tatlidede, A., Freitas, C., Cromer, J.R., Safar, L., Ongur, D., Stone, W.S., Seidman, L.J., Schmahmann, J.D., Pascual-Leone, A., Safety and proof of principle study of cerebellar vermal theta burst stimulation in refractory schizophrenia. Schizophr. Res. 124 (2010), 91–100.
12. Dlabac-de Lange, J.J., Knegtering, R., Aleman, A., Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J. Clin. Psychiatry 71 (2010), 411–418.
13. Dollfus, S., Lecardeur, L., Morello, R., Etard, O., Placebo response in repetitive transcranial magnetic stimulation trials of treatment of auditory hallucinations in schizophrenia: a meta-analysis. Schizophr. Bull. 42 (2016), 301–308.
14. Freitas, C., Fregni, F., Pascual-Leone, A., Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr. Res. 108 (2009), 11–24.
15. Fujimoto, T., Takeuch, K., Matsumoto, T., Kamimura, K., Hamada, R., Nakamura, K., Kato, N., Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia. Psychiatry Res. 154 (2007), 49–58.
16. Gaebel, W., Zielasek, J., Schizophrenia in 2020: Trends in diagnosis and therapy. Psychiatry Clin. Neurosci. 69 (2015), 661–673.
17. Garg, S., Tikka, S.K., Goyal, N., Sinha, V.K., Nizamie, S.H., Amelioration of anergia and thought disorder with adjunctive high frequency cerebellar vermal repetitive transcranial magnetic stimulation in schizophrenia: a case report. Schizophr. Res. 143 (2013), 225–227.
18. Garner, B., Phillips, L.J., Bendall, S., Hetrick, S.E., Antiglucocorticoid and related treatments for psychosis. Cochrane Database Syst. Rev., 2016, 1 CD006995.
19. Goghari, V.M., Sponheim, S.R., MacDonald, A.W. 3rd, The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. Neurosci. Biobehav. Rev. 34 (2010), 468–486.
20. Goyal, N., Nizamie, S.H., Desarkar, P., Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study. J. Neuropsychiatry Clin. Neurosci. 19 (2007), 464–467.
21. Guo, W., Liu, F., Chen, J., Wu, R., Zhang, Z., Yu, M., Xiao, C., Zhao, J., Resting-state cerebellar-cerebral networks are differently affected in first-episode, drug-naive schizophrenia patients and unaffected siblings. Sci. Rep., 5, 2015, 17275.
22. Hajak, G., Marienhagen, J., Langguth, B., Werner, S., Binder, H., Eichhammer, P., High-frequency repetitive transcranial magnetic stimulation in schizophrenia: A combined treatment and neuroimaging study. Psychol. Med. 34 (2004), 1157–1163.
23. Halko, M.A., Farzan, F., Eldaief, M.C., Schmahmann, J.D., Pascual-Leone, A., Intermittent theta-burst stimulation of the lateral cerebellum increases functional connectivity of the default network. J. Neurosci. 34 (2014), 12049–12056.
24. Hardwick, R.M., Lesage, E., Miall, R.C., Cerebellar transcranial magnetic stimulation: the role of coil geometry and tissue depth. Brain Stimul. 7 (2014), 643–649.
25. Heath, R., Franklin, D., Shraberg, D., Gross pathology of the cerebellum in patients diagnosed and treated as functional psychiatric disorders. J. Nerv. Ment. Dis. 167 (1979), 585–592.
26. Heringa, S.M., Begemann, M.J., Goverde, A.J., Sommer, I.E., Sex hormones and oxytocin augmentation strategies in schizophrenia: a quantitative review. Schizophr. Res. 168 (2015), 603–613.
27. Hovington, C.L., McGirr, A., Lepage, M., Berlim, M.T., Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analyses. Ann. Med. 45 (2013), 308–321.
28. Ichimiya, T., Okubo, Y., Suhara, T., Sudo, Y., Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia. Biol. Psychiatry 49 (2001), 20–27.
29. Iyer, M.B., Schleper, N., Wassermann, E.M., Priming stimulation enhances the depressant effect of low-frequency repetitive transcranial magnetic stimulation. J. Neurosci. 23 (2003), 10867–10872.
30. Jandl, M., Bittner, R., Sack, A., Weber, B., Günther, T., Pieschl, D., Kaschka, W.P., Maurer, K., Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. J. Neural Transm. 112 (2005), 955–967.
31. Kay, S.R., Opler, L.A., Lindenmayer, J.P., The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 13 (1987), 261–276.
32. Keck, M.E., Welt, T., Müller, M.B., Erhardt, A., Ohl, F., Toschi, N., Holsboer, F., Sillaber, I., Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 43 (2002), 101–109.
33. Kim, J.J., Mohamed, S., Andreasen, N.C., O'Leary, D.S., Watkins, G.L., Boles Ponto, L.L., Hichwa, R.D., Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography. Am. J. Psychiatry 157 (2000), 542–548.
34. Kim, W.S., Jung, S.H., Oh, M.K., Min, Y.S., Lim, J.Y., Paik, N.J., Effect of repetitive transcranial magnetic stimulation over the cerebellum on patients with ataxia after posterior circulation stroke: a pilot study. J. Rehabil. Med. 246 (2014), 418–423.
35. Koch, G., Brusa, L., Carrillo, F., Lo Gerfo, E., Torriero, S., Oliveri, M., Mir, P., Caltagirone, C., Stanzione, P., Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Neurology 73 (2009), 113–119.
36. Koch, G., Repetitive transcranial magnetic stimulation: a tool for human cerebellar plasticity. Funct. Neurol. 25 (2010), 159–163.
37. Koops, S., Dellen, E.V., Schutte, M.J., Nieuwdorp, W., Neggers, S.F., Sommer, I.E., Theta burst transcranial magnetic stimulation for auditory verbal hallucinations: negative findings from a double-blind-randomized trial. Schizophr. Bull. 42 (2016), 250–257.
38. Koutsouleris, N., Gaser, C., Jäger, M., Bottlender, R., Frodl, T., Holzinger, S., Schmitt, G.J., Zetzsche, T., Burgermeister, B., Scheuerecker, J., Born, C., Reiser, M., Möller, H.J., Meisenzahl, E.M., Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. NeuroImage 39 (2008), 1600–1612.
39. Lefaucheur, J.P., André-Obadia, N., Antal, A., Ayache, S.S., Baeken, C., Benninger, D.H., Cantello, R.M., Cincotta, M., de Carvalho, M., De Ridder, D., Devanne, H., Di Lazzaro, V., Filipović, S.R., Hummel, F.C., Jääskeläinen, S.K., Kimiskidis, V.K., Koch, G., Langguth, B., Nyffeler, T., Oliviero, A., Padberg, F., Poulet, E., Rossi, S., Rossini, P.M., Rothwell, J.C., Schönfeldt-Lecuona, C., Siebner, H.R., Slotema, C.W., Stagg, C.J., Valls-Sole, J., Ziemann, U., Paulus, W., Garcia-Larrea, L., Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin. Neurophysiol. 125 (2014), 2150–2206.
40. Lesage, E., Morgan, B.E., Olson, A.C., Meyer, A.S., Miall, R.C., Cerebellar rTMS disrupts predictive language processing. Curr. Biol. 22 (2012), R794–R795.
41. Lontis, E.R., Voigt, M., Struijk, J.J., Focality assessment in transcranial magnetic stimulation with double and cone coils. J. Clin. Neurophysiol. 23 (2006), 462–471.
42. Magalhães, P.V., Dean, O., Andreazza, A.C., Berk, M., Kapczinski, F., Antioxidant treatments for schizophrenia. Cochrane Database Syst. Rev., 2016, 2 CD008919.
43. Martin, P., Albers, M., Cerebellum and schizophrenia: a selective review. Schizophr. Bull. 21 (1995), 241–250.
44. McIntosh, A.M., Semple, D., Tasker, K., Harrison, L.K., Owens, D.G., Johnstone, E.C., Ebmeier, K.P., Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Res. 127 (2004), 9–17.
45. Minks, E., Kopickova, M., Marecek, R., Streitova, H., Bares, M., Transcranial magnetic stimulation of the cerebellum. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 154 (2010), 133–139.
46. Morellini, N., Grehl, S., Tang, A., Rodger, J., Mariani, J., Lohof, A.M., Sherrard, R.M., What does low-intensity rTMS do to the cerebellum?. Cerebellum 14 (2015), 23–26.
47. Nongpiur, A., Sinha, V.K., Praharaj, S.K., Goyal, N., Theta-patterned, frequency-modulated priming stimulation enhances low-frequency, right prefrontal cortex repetitive transcranial magnetic stimulation (rTMS) in depression: a randomized, sham-controlled study. J. Neuropsychiatry Clin. Neurosci. 23 (2011), 348–357.
48. Nopoulos, P.C., Ceilley, J.W., Gailis, E.A., Andreasen, N.C., An MRI study of cerebellar vermis morphology in patients with schizophrenia: evidence in support of the cognitive dysmetria concept. Biol. Psychiatry 46 (1999), 703–711.
49. Novák, T., Horácek, J., Mohr, P., Kopecek, M., Skrdlantová, L., Klirova, M., Rodriguez, M., Spaniel, F., Dockery, C., Höschl, C., The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuro Endocrinol. Lett. 27 (2006), 209–213.
50. Okugawa, G., Nobuhara, K., Takase, K., Kinoshita, T., Cerebellar posterior superior vermis and cognitive cluster scores in drug-naive patients with first-episode schizophrenia. Neuropsychobiology 56 (2007), 216–219.
51. Okugawa, G., Sedvall, G.C., Agartz, I., Smaller cerebellar vermis but not hemisphere volumes in patients with chronic schizophrenia. Am. J. Psychiatry 160 (2003), 1614–1617.
52. Orfanos, S., Banks, C., Priebe, S., Are group psychotherapeutic treatments effective for patients with schizophrenia? A systematic review and meta-analysis. Psychother. Psychosom. 84 (2015), 241–249.
53. Oya, K., Kishi, T., Iwata, N., Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials. Hum. Psychopharmacol. 29 (2014), 483–491.
54. Paulus, W., Toward establishing a therapeutic window for rTMS by theta burst stimulation. Neuron 45 (2005), 181–183.
55. Picard, H., Amado, I., Mouchet-Mages, S., Olié, J.P., Krebs, M.O., The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr. Bull. 34 (2008), 155–172.
56. Potkin, S.G., Alva, G., Fleming, K., Anand, R., Keator, D., Carreon, D., Doo, M., Jin, Y., Wu, J.C., Fallon, J.H., A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am. J. Psychiatry 159 (2002), 227–237.
57. Prikryl, R., Kasparek, T., Skotakova, S., Ustohal, L., Kucerova, H., Ceskova, E., Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr. Res. 95 (2007), 151–157.
58. Prikryl, R., Kucerova, H.P., Can repetitive transcranial magnetic stimulation be considered effective treatment option for negative symptoms of schizophrenia?. J. ECT 29 (2013), 67–74.
59. Rothwell, J.C., Hallett, M., Berardelli, A., Eisen, A., Rossini, P., Paulus, W., Magnetic stimulation: motor evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr. Clin. Neurophysiol. Suppl. 52 (1999), 97–103.
60. Sandrini, M., Umiltà, C., Rusconi, E., The use of transcranial magnetic stimulation in cognitive neuroscience: a new synthesis of methodological issues. Neurosci. Biobehav. Rev. 235 (2011), 516–536.
61. Sandyk, R., Kay, S.R., Merriam, A.E., Atrophy of the cerebellar vermis: Relevance to the symptoms of schizophrenia. Int. J. Neurosci. 57 (1991), 205–212.
62. Schutter, D.J., van Honk, J., d'Alfonso, A.A., Peper, J.S., Panksepp, J., High frequency repetitive transcranial magnetic over the medial cerebellum induces a shift in the prefrontal electroencephalography gamma spectrum: a pilot study in humans. Neurosci. Lett. 336 (2003), 73–76.
63. Shi, C., Yu, X., Cheung, E.F., Shum, D.H., Chan, R.C., Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis. Psychiatry Res. 215 (2014), 505–513.
64. Shim, S., Shuman, M., Duncan, E., An emerging role of cGMP in the treatment of schizophrenia: a review. Schizophr. Res. 170 (2016), 226–231.
65. Simpson, G.M., Angus, J.W., A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand. Suppl. 212 (1970), 11–19.
66. Tergau, F., Tormos, J.M., Paulus, W., Pascual-Leone, A., Ziemann, U., Effects of repetitive transcranial magnetic brain stimulation on cortico-spinal and cortico-cortical excitability (abstract). Neurology, 48, 1997, A107.
67. Tsapakis, E.M., Dimopoulou, T., Tarazi, F.I., Clinical management of negative symptoms of schizophrenia: an update. Pharmacol. Ther. 153 (2015), 135–147.
68. Wassermann, E.M., Risk and safety of repetitive transcranial magnetic stimulation: Report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996. Electroencephalogr. Clin. Neurophysiol. 108 (1998), 1–16.
69. Weinberger, D.R., Torrey, E.F., Wyatt, R.J., Cerebellar atrophy in chronic schizophrenia. Lancet 313 (1979), 718–719.
70. Wobrock, T., Guse, B., Cordes, J., Wölwer, W., Winterer, G., Gaebel, W., Langguth, B., Landgrebe, M., Eichhammer, P., Frank, E., Hajak, G., Ohmann, C., Verde, P.E., Rietschel, M., Ahmed, R., Honer, W.G., Malchow, B., Schneider-Axmann, T., Falkai, P., Hasan, A., Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial. Biol. Psychiatry 77 (2015), 979–988.
71. World Health Organization, The ICD-10 Classification of Mental and behavioral Disorders: Diagnostic Criteria for Research. 1992, World Health Organization, Geneva.
72. Yeganeh-Doost, P., Gruber, O., Falkai, P., Schmitt, A., The role of the cerebellum in schizophrenia: From cognition to molecular pathways. Clinics 66 (2011), 71–77.
73. Zhao, S., Kong, J., Li, S., Tong, Z., Yang, C., Zhong, H., Randomized controlled trial of four protocols of repetitive transcranial magnetic stimulation for treating the negative symptoms of schizophrenia. Shanghai Arch. Psychiatry 26 (2014), 15–21.